Details 
|
The Stanford Biodesign Innovation Program, in cooperation with Windhover Information, Wilson Sonsini Goodrich & Rosati and PricewaterhouseCoopers presents a unique opportunity to hear our second special guest for the 2004 series Eberhard Grube, interviewed by David Cassak, Managing Partner, Windhover Information.
Eberhard Grube is Chief of the Department of Cardiology and Angiology at the Heart Center Siegburg in Germany and Consulting Professor of Medicine at Stanford. He is internationally renowned as an innovator in the development and testing of new devices and procedures for cardiology. Over the past decade he has taken the lead in the initial clinical testing of drug-eluting stents, percutaneous closure devices, new atherectomy techniques, catheter-based valve surgery and treatment of vulnerable plaque. His broad experience and early exposure to a wide range of new devices not yet available in the U.S. contribute to his unique vision for the future of innovations in cardiovascular technology.
Most recently collaborating with the cardiovascular Core Analysis Laboratory in the observation of Intravascular Ultrasound (IVUS), Dr. Grube continues to be a pivotal player in the development and evaluation of leading medical technologies in the cardiovascular arena throughout the world.
|
|
|